PatientsVille.com Logo

PatientsVille

Pegatron Side Effects

Report Pegatron Side Effects

If you experienced any harmful or unwanted effects of Pegatron, please share your experience. This could help to raise awareness about Pegatron side effects, identify uknown risks and inform health professionals and patients taking Pegatron.

Examples: headache, dizziness


The most commonly reported Pegatron side effects are:
Optic Neuropathy (6 reports)
Extreme Exhaution (5 reports)
Jaw Ache (4 reports)
Dementia Confusion (3 reports)
Neutropenia (3 reports)
Exacerbation Of Psychiatric Problems (1 reports)
Neuropathy (1 reports)
Swollen Lymphnodes (1 reports)

If you have experienced a side effect listed above, you can check a box to report it.


To view a complete list of submitted side effects, please follow the link Pegatron side effects . You can also compare Pegatron side effects or view FDA reports.

Pegatron Side Effects reported to FDA

The following Pegatron reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Pegatron on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Page 1 of 3 

Affective Disorder, Anorexia, Fatigue, Haematemesis, Insomnia, Nausea
on Jul 19, 2007 Male from AUSTRALIA , 56 years of age, was diagnosed with and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. Directly after, patient experienced the unwanted or unexpected Pegatron side effects: affective disorder, anorexia, fatigue, haematemesis, insomnia, nausea. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: N/A.

Cardiac Arrest, Malaise
Patient was taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. Patient felt the following Pegatron side effects: cardiac arrest, malaise on Mar 27, 2009 from AUSTRALIA Additional patient health information: Female , 48 years of age, was diagnosed with and. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: N/A. Patient was hospitalized.

Acute Respiratory Distress Syndrome, Multi-organ Failure, Pneumonia, Septic Shock
Adverse event was reported on Feb 03, 2009 by a Male taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf (Dosage: 120 Mcg; Qw;, 1000 Mg; Qd;) was diagnosed with and. Location: AUSTRALIA , 53 years of age, weighting 163.1 lb, After Pegatron was administered, patient encountered several Pegatron side effects: acute respiratory distress syndrome, multi-organ failure, pneumonia, septic shock. Patient was hospitalized.

Acute Respiratory Distress Syndrome, Pneumonia, Septic Shock
on Jan 30, 2009 Male from AUSTRALIA , 53 years of age, weighting 163.1 lb, was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Inter. Directly after, patient experienced the unwanted or unexpected Pegatron side effects: acute respiratory distress syndrome, pneumonia, septic shock. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Inter dosage: 0.5 Ml;qw;, 1000 Mg;qd;.
Associated medications used: Patient was hospitalized.


Acute Respiratory Distress Syndrome, Pneumonia, Septic Shock
on Dec 17, 2008 Male from AUSTRALIA , 53 years of age, weighting 163.1 lb, was treated with Pegatron (peginterferon Alfa-2b W/ Ribavirin) (pegylated Interferon Al. Patient felt the following Pegatron side effects: acute respiratory distress syndrome, pneumonia, septic shock. Pegatron (peginterferon Alfa-2b W/ Ribavirin) (pegylated Interferon Al dosage: 0.5 Ml, Qw; 1000 Mg, Qd,. Patient was hospitalized.

Cholelithiasis
Patient was taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. After Pegatron was administered, patient encountered several Pegatron side effects: cholelithiasis on Dec 03, 2008 from AUSTRALIA Additional patient health information: Female , 51 years of age, was diagnosed with and. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: 0.45 Ml; 400 Mg, Qam; 600 Mg; Hs;. Patient was hospitalized.

Cholelithiasis
Adverse event was reported on Nov 18, 2008 by a Female taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf (Dosage: N/A) was diagnosed with and. Location: AUSTRALIA , 51 years of age, Directly after, patient experienced the unwanted or unexpected Pegatron side effects: cholelithiasis. Patient was hospitalized.

Hepatic Failure
on Nov 10, 2008 Patient from AUSTRALIA , weighting 222.7 lb, was diagnosed with and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. Patient felt the following Pegatron side effects: hepatic failure. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: 150 Mcg;qw;, 12-- Mg;qd;.

Asthenia, Dizziness, Dyspnoea
on Sep 10, 2008 Female from AUSTRALIA , 26 years of age, was diagnosed with and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. After Pegatron was administered, patient encountered several Pegatron side effects: asthenia, dizziness, dyspnoea. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: 80 Mcg; 800 Mg;.

Hospitalisation
Patient was taking Pegatron (peginterferon Alfa-28 W/ribavirin) (pegylated Interferon Alf. Directly after, patient experienced the unwanted or unexpected Pegatron side effects: hospitalisation on Sep 15, 2008 from AUSTRALIA Additional patient health information: Male , weighting 163.1 lb, . Pegatron (peginterferon Alfa-28 W/ribavirin) (pegylated Interferon Alf dosage: 0.5 Ml; Qw; 1000 Mg; Qd. Patient was hospitalized.

Chest Pain, Hypertension, Vision Blurred
Adverse event was reported on Jul 09, 2008 by a Male taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf (Dosage: 100 Mcg; Qw; Sc, 100 Mg; Qd; Po) was diagnosed with and. Location: AUSTRALIA , 74 years of age, Patient felt the following Pegatron side effects: chest pain, hypertension, vision blurred. Patient was hospitalized.

Multi-organ Failure, Sepsis
on Jun 25, 2008 Male from AUSTRALIA , 46 years of age, was diagnosed with and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. After Pegatron was administered, patient encountered several Pegatron side effects: multi-organ failure, sepsis. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: See Image.

Atrioventricular Block First Degree, Bradycardia, Chest Pain, Hypertension, Vision Blurred
on Jun 19, 2008 Male from AUSTRALIA , 74 years of age, was diagnosed with and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. Directly after, patient experienced the unwanted or unexpected Pegatron side effects: atrioventricular block first degree, bradycardia, chest pain, hypertension, vision blurred. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: 100 Mcg; Qw; Sc, 100 Mg; Qd; Po. Patient was hospitalized.

Multi-organ Failure, Sepsis
Patient was taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. Patient felt the following Pegatron side effects: multi-organ failure, sepsis on Jun 17, 2008 from AUSTRALIA Additional patient health information: Male , 46 years of age, was diagnosed with and. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: ; Po, ; Sc.

Chest Discomfort, Chest Pain, Hypertension, Vision Blurred
Adverse event was reported on May 29, 2008 by a Male taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf (Dosage: 100 Mcg; Qw; Sc, 100 Mg; Qd; Po) was diagnosed with and. Location: AUSTRALIA , 74 years of age, After Pegatron was administered, patient encountered several Pegatron side effects: chest discomfort, chest pain, hypertension, vision blurred. Patient was hospitalized.

Chest Pain, Hypertension, Vision Blurred
on May 14, 2008 Male from AUSTRALIA , 74 years of age, was diagnosed with and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. Directly after, patient experienced the unwanted or unexpected Pegatron side effects: chest pain, hypertension, vision blurred. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: 100 Mcg,qw;sc;po. Patient was hospitalized.

Haemoglobin Abnormal, Neutrophil Count Increased, Subarachnoid Haemorrhage, White Blood Cell Count Increased
on Feb 05, 2008 Male from NEW ZEALAND , 52 years of age, was diagnosed with and was treated with Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interfer. Patient felt the following Pegatron side effects: haemoglobin abnormal, neutrophil count increased, subarachnoid haemorrhage, white blood cell count increased. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interfer dosage: 100 Mcg; Qw; Sc; 800 Mg; Qd; Po.
Multiple prescriptions taken: Patient was hospitalized.

Subarachnoid Haemorrhage
Patient was taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf. After Pegatron was administered, patient encountered several Pegatron side effects: subarachnoid haemorrhage on Jan 21, 2008 from NEW ZEALAND Additional patient health information: Male , 52 years of age, was diagnosed with and. Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf dosage: 100 Mcg; Qw; Sc, 800 Mg; Qd; Po. Patient was hospitalized.

Cardiac Disorder
Adverse event was reported on Jan 16, 2008 by a Female taking Pegatron (peginterferon Alfa-2b W/ribavirin) (pegylated Interferon Alf (Dosage: ; Sc; Po) was diagnosed with and. Location: AUSTRALIA , 40 years of age, Directly after, patient experienced the unwanted or unexpected Pegatron side effects: cardiac disorder. Patient was hospitalized.

Glaucoma
on Nov 20, 2007 Male from AUSTRALIA , 51 years of age, weighting 178.6 lb, was diagnosed with and was treated with Pegatron (pegylated Interferon Alfa-2b W/ribavirin). Patient felt the following Pegatron side effects: glaucoma. Pegatron (pegylated Interferon Alfa-2b W/ribavirin) dosage: See Image.

Amenorrhoea, Anorexia, Lethargy, Nausea, Rectal Haemorrhage, Vaginal Neoplasm
on Oct 08, 2007 Female from AUSTRALIA , 43 years of age, was diagnosed with and was treated with Pegatron (pegylated Interferon Alfa-2b W/ribavirin). After Pegatron was administered, patient encountered several Pegatron side effects: amenorrhoea, anorexia, lethargy, nausea, rectal haemorrhage, vaginal neoplasm. Pegatron (pegylated Interferon Alfa-2b W/ribavirin) dosage: ; Sc, ;po.
Multiple concurrent drugs taken:

Deep Vein Thrombosis, Disorientation, Dyspnoea, Emotional Disorder, Visual Acuity Reduced
Patient was taking Pegatron (pegylated Interferon Alfa-2b W/ribavirin). Directly after, patient experienced the unwanted or unexpected Pegatron side effects: deep vein thrombosis, disorientation, dyspnoea, emotional disorder, visual acuity reduced on Oct 08, 2007 from AUSTRALIA Additional patient health information: Male , 44 years of age, was diagnosed with and. Pegatron (pegylated Interferon Alfa-2b W/ribavirin) dosage: ; Sc, ; Po.

Amenorrhoea, Anorexia, Lethargy, Mass, Nausea, Rectal Haemorrhage, Vaginal Disorder
Adverse event was reported on Jul 17, 2007 by a Female taking Pegatron (pegylated Interferon Alfa-2b W/ribavirin) (Dosage: Sc; Po) was diagnosed with and. Location: AUSTRALIA , 43 years of age, Patient felt the following Pegatron side effects: amenorrhoea, anorexia, lethargy, mass, nausea, rectal haemorrhage, vaginal disorder.

Deep Vein Thrombosis, Disorientation, Dyspnoea, Mood Altered, Visual Acuity Reduced
on Jun 04, 2007 Male from AUSTRALIA , 44 years of age, was diagnosed with and was treated with Pegatron (pegylated Interferon Alfa-2b W/ribavirin). After Pegatron was administered, patient encountered several Pegatron side effects: deep vein thrombosis, disorientation, dyspnoea, mood altered, visual acuity reduced. Pegatron (pegylated Interferon Alfa-2b W/ribavirin) dosage: Sc.

Amnesia, Confusional State, Delirium, Disorientation, Fall, Fibula Fracture, Infection, Insomnia, Joint Dislocation
on Feb 21, 2007 Male from AUSTRALIA , 41 years of age, was diagnosed with and was treated with Pegatron (pegylated Interferon Alfa-2b W/ribavirin). Directly after, patient experienced the unwanted or unexpected Pegatron side effects: amnesia, confusional state, delirium, disorientation, fall, fibula fracture, infection, insomnia, joint dislocation. Pegatron (pegylated Interferon Alfa-2b W/ribavirin) dosage: See Image. Patient was hospitalized.

Page 1 of 3 

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Pegatron

Find Out How to Take Pegatron

Discuss Pegatron Side Effects

Did You Have a Pegatron Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Pegatron for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

More About Pegatron

Side Effects reported to FDA: 63

Pegatron safety alerts: No

Reported deaths: 5

Reported hospitalizations: 23

Latest Pegatron clinical trials